Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch... see more

TSX:SVA - Post Discussion

Sernova Corp > Perspective
View:
Post by MoneyMouth on Apr 02, 2022 5:49pm

Perspective

Just to give some perspective, in like July of 2016, Sernova announced that the JDRF would help sponsor and bring the cell pouch towards their first in-human clinical trial.

In December 2017, a year and a half later, the FDA approved and authorized the initiation of the first in-human clinical trial.

In December of 2018, the first patient was enrolled in that study. 1 full year later.

In January of 2021, Three years later, that first patient was announced as insulin independence. And what was started 4 years prior had finally bared fruit, share prrice wise.

Now we are in 2022, and suddenly we ask ourselves why is management so slow?? Did we ask these questions in 2017? Or 18? Yeah! Did anything change? No not really.

Unless something changes, past performance is a good indicator of future performance. So strap in until 2025...
Comment by MustangSalley on Apr 03, 2022 12:32am
Mouth, I don't disagree with your points at all. But what I am afraid is that the global economic market collapse like 1928 . It won't matter if Sva has success in 2026 or 2027.  The clock is running and it's not the competiton , a severe lasting correction in the current monetary system has begun.  Conformal coding  and stem cell in a clinical trial will be years ...more  
Comment by quest13 on Apr 03, 2022 6:21pm
Hello again Sailboat, jwallisca, MustangSally, and MoneyMouth  I have read Postings from yourselves which I generally agree with.  The passage of time in getting approval for the use of this device and Insulin generating cells in human beings is unfortunate. I am also concerned that number 7 has been identified but we have heard nothing more about 7 having the device installed. I am ...more  
Comment by Metalsguy1 on Apr 04, 2022 12:00am
mustangsalley. When did you decide to get into comedy writing? Management should give an update! The only thing management gives us is a solid middle finger.
Comment by MoneyMouth on Apr 04, 2022 2:15am
The point of my post was that when people say these things take time, they mean it. I don't quite understand in detail why it takes so long, but it I guess it just does. If anyone has some insight into why exactly it takes a year for anything to progress one step forward that would be appreciated. On one hand though, If it is just a year for things to progress then hey, its been a year since ...more  
Comment by BioTeck on Apr 04, 2022 11:41am
Porcine cells. I bet that is the Diatranz product that Living Cell Tech sold to Otsuka after their parkinson treatmeant failed. Another name that keeps popping up over the years. My guess is it is nothing more than these companies trying their products at the cost of Sernova Shareholders. They keep kicking tires and learn more about their own product and getting pre-clinical info for free using ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities